Literature DB >> 31633754

Matrix metalloproteinases cleave membrane-bound PD-L1 on CD90+ (myo-)fibroblasts in Crohn's disease and regulate Th1/Th17 cell responses.

Jose E Aguirre1,2, Ellen J Beswick3, Carl Grim1, Gabriela Uribe1,4, Marissa Tafoya5, Gabriela Chacon Palma6, Von Samedi6, Rohini McKee7, Romain Villeger1, Yuriy Fofanov8, Yingzi Cong9, Gregory Yochum10, Walter Koltun11, Don Powell1,2, Irina V Pinchuk1,2,4,9.   

Abstract

Increased T helper (Th)1/Th17 immune responses are a hallmark of Crohn's disease (CD) immunopathogenesis. CD90+ (myo-)fibroblasts (MFs) are abundant cells in the normal (N) intestinal mucosa contributing to mucosal tolerance via suppression of Th1 cell activity through cell surface membrane-bound PD-L1 (mPD-L1). CD-MFs have a decreased level of mPD-L1. Consequently, mPD-L1-mediated suppression of Th1 cells by CD-MFs is decreased, yet the mechanism responsible for the reduction in mPDL-1 is unknown. Increased expression of matrix metalloproteinases (MMPs) has been reported in CD. Herein we observed that when compared to N- and ulcerative colitis (UC)-MFs, CD-MFs increase in LPS-inducible levels of MMP-7 and -9 with a significant increase in both basal and inducible MMP-10. A similar pattern of MMP expression was observed in the CD-inflamed mucosa. Treatment of N-MFs with a combination of recombinant human MMP-7, -9 and -10 significantly decreased mPD-L1. In contrast, inhibition of MMP activity with MMP inhibitors or anti-MMP-10 neutralizing antibodies restores mPD-L1 on CD-MFs. CD-MFs demonstrated reduced capacity to suppress Th1 and Th17 responses from activated CD4+ T cells. By contrast, supplementation of the CD-MF:T-cell co-cultures with MMP inhibitors or anti-MMP neutralizing antibodies restored the CD-MF-mediated suppression. Our data suggest that (i) increased MMP-10 expression by CD-MFs and concomitant cleavage of PD-L1 from the surface of CD-MFs are likely to be one of the factors contributing to the decrease of mPD-L1-mediated suppression of Th1/Th17 cells in CD; and (ii) MMPs are likely to have a significant role in the intestinal mucosal immune responses. © The Japanese Society for Immunology. 2019. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Crohn’s disease; matrix metalloproteinases; membrane-bound and soluble PD-L1; myo-/fibroblasts

Mesh:

Substances:

Year:  2020        PMID: 31633754      PMCID: PMC7185192          DOI: 10.1093/intimm/dxz060

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  51 in total

1.  Vascular smooth muscle cells and pericytes express MMP-1, MMP-9, TIMP-1 and type I procollagen in inflammatory bowel disease.

Authors:  S Arihiro; H Ohtani; N Hiwatashi; A Torii; T Sorsa; H Nagura
Journal:  Histopathology       Date:  2001-07       Impact factor: 5.087

Review 2.  Regulation and Function of the PD-L1 Checkpoint.

Authors:  Chong Sun; Riccardo Mezzadra; Ton N Schumacher
Journal:  Immunity       Date:  2018-03-20       Impact factor: 31.745

3.  Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease.

Authors:  E Cario; D K Podolsky
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

Review 4.  Regulation of matrix metalloproteinases: an overview.

Authors:  Sajal Chakraborti; Malay Mandal; Sudip Das; Amritlal Mandal; Tapati Chakraborti
Journal:  Mol Cell Biochem       Date:  2003-11       Impact factor: 3.396

5.  Matrilysin (MMP-7) induces homotypic adhesion of human colon cancer cells and enhances their metastatic potential in nude mouse model.

Authors:  Mitomu Kioi; Kazuhiro Yamamoto; Shouichi Higashi; Naohiko Koshikawa; Kiyohide Fujita; Kaoru Miyazaki
Journal:  Oncogene       Date:  2003-11-27       Impact factor: 9.867

Review 6.  Soluble PD-1 and PD-L1: predictive and prognostic significance in cancer.

Authors:  Xinxin Zhu; Jinghe Lang
Journal:  Oncotarget       Date:  2017-05-31

7.  CD90(+) Stromal Cells are Non-Professional Innate Immune Effectors of the Human Colonic Mucosa.

Authors:  Benjamin M J Owens; Tessa A M Steevels; Michael Dudek; David Walcott; Mei-Yi Sun; Alice Mayer; Philip Allan; Alison Simmons
Journal:  Front Immunol       Date:  2013-09-30       Impact factor: 7.561

8.  A novel regulation of PD-1 ligands on mesenchymal stromal cells through MMP-mediated proteolytic cleavage.

Authors:  Colette Dezutter-Dambuyant; Isabelle Durand; Laurent Alberti; Nathalie Bendriss-Vermare; Jenny Valladeau-Guilemond; Adeline Duc; Audrey Magron; Anne-Pierre Morel; Vanja Sisirak; Céline Rodriguez; David Cox; Daniel Olive; Christophe Caux
Journal:  Oncoimmunology       Date:  2015-10-29       Impact factor: 8.110

9.  Regulation of programmed-death ligand in the human head and neck squamous cell carcinoma microenvironment is mediated through matrix metalloproteinase-mediated proteolytic cleavage.

Authors:  Mayuko Hira-Miyazawa; Hiroyuki Nakamura; Mariko Hirai; Yutaka Kobayashi; Hiroko Kitahara; George Bou-Gharios; Shuichi Kawashiri
Journal:  Int J Oncol       Date:  2017-12-11       Impact factor: 5.650

10.  Intestinal APCs of the endogenous nanomineral pathway fail to express PD-L1 in Crohn's disease.

Authors:  Jack Robertson; Carolin T Haas; Laetitia C Pele; Tom P Monie; Charles Charalambos; Miles Parkes; Rachel E Hewitt; Jonathan J Powell
Journal:  Sci Rep       Date:  2016-05-26       Impact factor: 4.379

View more
  11 in total

Review 1.  Digestive Inflammation: Role of Proteolytic Dysregulation.

Authors:  Vincent Mariaule; Aicha Kriaa; Souha Soussou; Soufien Rhimi; Houda Boudaya; Juan Hernandez; Emmanuelle Maguin; Adam Lesner; Moez Rhimi
Journal:  Int J Mol Sci       Date:  2021-03-10       Impact factor: 5.923

2.  Impairment of Tissue-Resident Mesenchymal Stem Cells in Chronic Ulcerative Colitis and Crohn's Disease.

Authors:  Carl Grim; Robert Noble; Gabriela Uribe; Kamil Khanipov; Paul Johnson; Walter A Koltun; Tammara Watts; Yuriy Fofanov; Gregory S Yochum; Don W Powell; Ellen J Beswick; Irina V Pinchuk
Journal:  J Crohns Colitis       Date:  2021-08-02       Impact factor: 9.071

3.  CMTM6-Deficient Monocytes in ANCA-Associated Vasculitis Fail to Present the Immune Checkpoint PD-L1.

Authors:  Markus Zeisbrich; Nina Chevalier; Bettina Sehnert; Marta Rizzi; Nils Venhoff; Jens Thiel; Reinhard E Voll
Journal:  Front Immunol       Date:  2021-05-24       Impact factor: 7.561

Review 4.  Role of PD-L1 in Gut Mucosa Tolerance and Chronic Inflammation.

Authors:  Marina Chulkina; Ellen J Beswick; Irina V Pinchuk
Journal:  Int J Mol Sci       Date:  2020-12-01       Impact factor: 5.923

Review 5.  Interrelation Between Fibroblasts and T Cells in Fibrosing Interstitial Lung Diseases.

Authors:  Yunxin Lai; Xinru Wei; Ting Ye; Lilin Hang; Ling Mou; Jin Su
Journal:  Front Immunol       Date:  2021-11-05       Impact factor: 7.561

Review 6.  Journey through Crohn's Disease Complication: From Fistula Formation to Future Therapies.

Authors:  Federica Rubbino; Luana Greco; Alessio di Cristofaro; Federica Gaiani; Stefania Vetrano; Luigi Laghi; Stefanos Bonovas; Daniele Piovani
Journal:  J Clin Med       Date:  2021-11-26       Impact factor: 4.241

7.  Fibroblast-like cells Promote Wound Healing via PD-L1-mediated Inflammation Resolution.

Authors:  Xiao-Hui Wang; Wei Guo; Wei Qiu; Luo-Quan Ao; Meng-Wei Yao; Wei Xing; Yang Yu; Quan Chen; Xiao-Feng Wu; Zhan Li; Xue-Ting Hu; Xiang Xu
Journal:  Int J Biol Sci       Date:  2022-07-04       Impact factor: 10.750

8.  Molecular Footprints of the Immune Assault on Pancreatic Beta Cells in Type 1 Diabetes.

Authors:  Maikel L Colli; Florian Szymczak; Decio L Eizirik
Journal:  Front Endocrinol (Lausanne)       Date:  2020-09-15       Impact factor: 5.555

Review 9.  Exosomal PD-L1: New Insights Into Tumor Immune Escape Mechanisms and Therapeutic Strategies.

Authors:  Kaijian Zhou; Shu Guo; Fei Li; Qiang Sun; Guoxin Liang
Journal:  Front Cell Dev Biol       Date:  2020-10-15

10.  Elevated Pre-Treatment Serum MMP-7 Levels Are Associated with the Presence of Metastasis and Poor Survival in Upper Tract Urothelial Carcinoma.

Authors:  Petra Terézia Kovács; Tamás Mayer; Anita Csizmarik; Melinda Váradi; Csilla Oláh; Ádám Széles; Stephan Tschirdewahn; Ulrich Krafft; Boris Hadaschik; Péter Nyirády; Péter Riesz; Tibor Szarvas
Journal:  Biomedicines       Date:  2022-03-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.